FDA — authorised 19 April 1957
- Status: approved
🇺🇸 Raunormin in United States
FDA authorised Raunormin on 19 April 1957
Marketing authorisations
FDA — authorised 19 April 1957
- Application: NDA010796
- Marketing authorisation holder: ABBVIE
- Local brand name: HARMONYL
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 1 August 1961
- Application: NDA012775
- Marketing authorisation holder: ABBOTT
- Local brand name: ENDURONYL FORTE
- Indication: TABLET — ORAL
- Status: approved
FDA
- Application: ANDA088452
- Marketing authorisation holder: WATSON LABS
- Local brand name: METHYCLOTHIAZIDE AND DESERPIDINE
- Indication: TABLET — ORAL
- Status: approved
Raunormin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United States
Frequently asked questions
Is Raunormin approved in United States?
Yes. FDA authorised it on 19 April 1957; FDA authorised it on 19 April 1957; FDA authorised it on 1 August 1961.
Who is the marketing authorisation holder for Raunormin in United States?
Marketing authorisation holder not available in our data.